Tier 4 — mechanistic
Dietary Supplementation With NAD+-Boosting Compounds in Humans: Current Knowledge and Future Directions
The journals of gerontology. Series A, Biological sciences and medical sciences
2023
78; 12; 2435-2448
Bibliography
- PubMed
- PMID 37068054
- PubMed Central
- PMC10692436
- Funding
- Indexed grant support includes NHLBI NIH HHS, NIA NIH HHS, NIH HHS. The complete funding declaration is not specified in the accessible abstract.
- Competing interests
- The authors disclosed a ChromaDex material-transfer agreement and reported no commercial or financial relationships considered conflicts.
Study snapshot
| Design | Narrative evidence review |
|---|---|
| Model | Published clinical research literature |
| Sample | Human studies of NR, NR/pterostilbene and NMN |
| Intervention | Review of chronic oral NAD+-precursor supplementation |
| Duration | Studies available through the review’s search period |
| Endpoints | Evidence synthesis and translational limitations |
What the study showed, in plain terms
Key findings
What this study can and cannot tell us
Editorial review
Reviewed by the Biohack Blueprint research team
Last verified
